Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Net Sales
1,050.09
902.73
Other Operating Income
0.00
0.00
Total Operating income
1,050.09
902.73
Raw Material Cost
75.79
76.40
Purchase of Finished goods
104.03
112.19
(Increase) / Decrease In Stocks
14.88
-8.93
Employee Cost
296.38
261.29
Power Cost
0.00
0.00
Manufacturing Expenses
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
Other Expenses
327.60
276.02
Total Expenditure (Excl Depreciation)
818.68
716.97
Operating Profit (PBDIT) excl Other Income
231.41
185.76
Other Income
6.53
4.51
Operating Profit (PBDIT)
237.94
190.27
Interest
5.58
8.41
Exceptional Items
-19.10
0.00
Gross Profit (PBDT)
213.26
181.86
Depreciation
27.57
27.12
Profit Before Tax
185.71
154.92
Tax
45.89
37.04
Provisions and contingencies
0.00
0.00
Profit After Tax
139.80
117.70
Extraordinary Items
0.00
0.00
Prior Period Expenses
0.00
0.00
Other Adjustments
0.00
0.00
Net Profit
139.80
117.70
Share in Profit of Associates
-0.01
0.17
Minority Interest
0.00
0.00
Other related items
0.00
0.00
Consolidated Net Profit
139.79
117.87
Equity Capital
61.16
61.16
Face Value
10.0
10.0
Reserves
0.00
0.00
Diluted Earnings per share
6.75
7.35
Operating Profit Margin (Excl OI)
22.04%
20.58%
Gross Profit Margin
20.31%
20.15%
PAT Margin
13.31%
13.04%
Public Share Holdings (%)
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 16.32%
Standalone Net Profit
YoY Growth in nine months ended Dec 2025 is 18.78%
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 24.57%
Interest
YoY Growth in nine months ended Dec 2025 is -33.65%
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Corona Remedies With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
1,050.09
1,498.30
-448.21
-29.91%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,050.09
1,498.30
-448.21
-29.91%
Raw Material Cost
75.79
252.10
-176.31
-69.94%
Purchase of Finished goods
104.03
325.80
-221.77
-68.07%
(Increase) / Decrease In Stocks
14.88
151.60
-136.72
-90.18%
Employee Cost
296.38
186.40
109.98
59.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
327.60
209.90
117.70
56.07%
Total Expenditure (Excl Depreciation)
818.68
1,125.80
-307.12
-27.28%
Operating Profit (PBDIT) excl Other Income
231.41
372.50
-141.09
-37.88%
Other Income
6.53
10.60
-4.07
-38.40%
Operating Profit (PBDIT)
237.94
383.10
-145.16
-37.89%
Interest
5.58
1.10
4.48
407.27%
Exceptional Items
-19.10
53.90
-73.00
-135.44%
Gross Profit (PBDT)
213.26
336.30
-123.04
-36.59%
Depreciation
27.57
27.10
0.47
1.73%
Profit Before Tax
185.71
309.20
-123.49
-39.94%
Tax
45.89
86.80
-40.91
-47.13%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
139.80
222.40
-82.60
-37.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
99.60
-99.60
-100.00%
Net Profit
139.80
322.00
-182.20
-56.58%
Share in Profit of Associates
-0.01
0.00
-0.01
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
139.79
322.00
-182.21
-56.59%
Equity Capital
61.16
23.00
38.16
165.91%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
20.31%
22.45%
0.00
-2.14%
PAT Margin
13.31%
14.84%
0.00
-1.53%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,050.09 Cr
in Dec 2025Figures in Cr
Nine Monthly - Standalone Net Profit
Standalone Net Profit 139.80 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 231.41 Cr
in Dec 2025Figures in Cr
Nine Monthly - Interest
Interest 5.58 Cr
in Dec 2025Figures in Cr
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.04%
in Dec 2025Figures in %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
